Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
175 Cards in this Set
- Front
- Back
HEPATITIS - CIBULL - WEDNESDAY FEB 7
|
|
|
|
|
|
define: hepatitis
|
a generic term for hepatocellular necrosis with variable degrees of inflammation +/- other features such as cholestasis, etc.
|
|
|
|
|
VIRAL HEPATITIS
|
|
|
|
|
|
during what phase are the morphologic changes of all types of viral hepatitis similar?
|
during the acute phase
|
|
what are the morphologic changes like in the acute phase (what areas are involved, and what areas are accentuated)?
|
patchy involvement of the entire lobule, with slight accentuation around the region around the central vein
|
|
what type of degeneration occurs in acute hepatitis?
|
ballooning degeneration
|
|
what are hepatocytes like, and what particular change has happened to some?
|
necrotic hepatocytes, some which have become mummified (acidophil bodies)
|
|
what cells are prominent in acute hepatitis?
|
Kupffer cells
|
|
does regeneration generally occur in acute hepatitis?
|
yes
|
|
what else occurs (list)?
|
inflammation, variable cholestasis, variable fatty change, etc.
|
|
what are the systemic clinical symptoms of acute hepatitis (5)?
|
1) malaise; 2) anorexia; 3) nausea; 4) fever (usually low grade); 5) immunologic findings (rash, arthritis, others)
|
|
what is urine like in acute hepatitis?
|
dark
|
|
what are other liver-relates symptoms of acute hepatitis (3)?
|
1) RUQ pain/tenderness; 2) jaundice; 3) itching
|
|
which hepatitis virus is a DNA virus?
|
HBV
|
|
what is the epidemiology of hepatitis A, B, and C?
|
A: fecal oral; B and C: parenteral
|
|
what is the incubation period for hepatitis A, B, and C?
|
2-6 weeks, 7-12 weeks, and 2-20 weeks
|
|
which can be spread through the blood?
|
B and C
|
|
which can be spread through feces?
|
A, possibly C
|
|
which can be spread by saliva?
|
A, B, and C
|
|
which can be spread perinatally?
|
B and C
|
|
how common is heterosexual sexual spread of hepatitis A, B, and C?
|
unknown, common, and uncommon
|
|
how common is homosexual sexual spread of hepatitis A, B, and C?
|
common, common, uncommon
|
|
how common is intra-family spread of hepatitis A, B, and C?
|
common, uncommon, uncommon
|
|
what is the icteric to anti icteric ratio of hepatitis A, B, and C?
|
1 to 1, 1 to 2, 1 to 4
|
|
all types may have a mild acute episode, but which type may have a severe acute episode as well?
|
HBV
|
|
which form has an abrupt onset?
|
HAV
|
|
what is the frequency of serum sickness-like-illness in hepatitis A, B, and C?
|
uncommon, common, rare
|
|
what is the mortality of hepatitis A, B, and C?
|
<0.5%, 1-3%, 1-2%
|
|
what is the rate of chronicity in hepatitis A, B, and C?
|
none, 5-10%, 50% or more
|
|
which increase the chance of liver cancer?
|
B and C
|
|
which has frequent transaminase fluctuation?
|
HCV
|
|
what is the antibody prevalence % in A, B, and C?
|
35-45%, 5-15%, 1-2%
|
|
what % of sporadic hepatitis cases are due to A, B, and C?
|
20%, 60%, 20%
|
|
what % of fulminant hepatitis cases are due to A, B, and C?
|
5%, 60%, 35%
|
|
what % of posttransfusion hepatitis cases are due to A, B, and C?
|
0%, 60%, 40%
|
|
what % of hepatitis cases in medical personnel cases are due to A, B, and C?
|
rare, 80%, 20%
|
|
what % of hepatitis cases in drug addicts are due to A, B, and C?
|
20%, 60%, 20%
|
|
what % of hepatitis cases in gay men are due to A, B, and C?
|
35%, 60%, 5%
|
|
what % of hepatitis cases in travelers are due to A, B, and C?
|
80%, 15%, 5%
|
|
of hepatitis B and C, which is most easily transmitted parenterally and by sexual contact?
|
hepatitis B is more easily transmitted both by sexual contact and parenterally
|
|
what % of HBV and what % of HCV cases have no risk factors?
|
30%, 40%
|
|
after personal contact, what is the most common source of HAV infection in the USA?
|
day care centers
|
|
what % of hepatitis A, B, and C virus recover completely?
|
99%, 85%, 15%
|
|
what % of patients with hepatis A, B, and C undergo massive hepatic necrosis?
|
<1%, 1%, 1-3%
|
|
of those who have massive hepatic necrosis with hepatitis A, B, and C, what % of each die?
|
50%, 67%, 87%
|
|
what is massive hepatic necrosis characterized by, histologicallly?
|
marked and uniform loss of hepatocytes with stromal collapse and loss of whole lobules
|
|
what happens later, if patient lives (2)?
|
1) fibrosis; 2) ductal proliferation
|
|
is this a type of cirrhosis?
|
no
|
|
what is the most common cause of liver failure?
|
acetaminophen (then other drugs, then hepatitis and other diseases)
|
|
|
|
|
HEPATITIS A VIRUS
|
|
|
|
|
|
what family is the hepatitis A virus?
|
picornavirus
|
|
what is the average incubation period for HAV, and what is the range?
|
average 30 days, range 15-50 days
|
|
what age group is most likely to get jaundice with HAV, and what % get it?
|
>14 yrs (70-80%)
|
|
what % of 6-14 year olds, and <6 yrs, get jaundice with HAV?
|
6-14 yrs: 40-50%
|
|
what are complications of HAV (3)?
|
1) fulminant hepatitis; 2) cholestatic hepatitis; 3) relapsing hepatitis
|
|
what are the chronic sequelae of HAV?
|
none
|
|
what age group has the highest mortality for HAV?
|
the elderly, by far: those over 49 have 17.5 per 1000 die, while those ages 30-49 have only 3.8 - those under 5 have slightly higher (3/1000) than those who are 5-29 (1.6/1000)
|
|
where is the highest concentration of infections HAV, and what is the concentration?
|
feces: 10^9 (infectious doses/ml)
|
|
what is the concentration in the serum and saliva?
|
serum is nearly 10^5, saliva just under 10^3 (infectious doses/ml)
|
|
|
|
|
HEPATITIS B VIRUS
|
|
|
|
|
|
what is the average incubation period, and incubation period range, of HBV?
|
average 60-90 days, range 45-180 days
|
|
what % get clinical illness (jaundice) with HBV, in those <5yr, and those >5yr?
|
<5yr, <10%; >5yr, 30-50%
|
|
what is the acute case fatality rate in hepatitis B?
|
0.5-1%
|
|
what % of those get chronic infection, in those <5yrs, and those >5yr?
|
<5yr, 30-90%, >5yr, 2-10%
|
|
what % have premature mortality from chronic liver disease?
|
15-25%
|
|
what are the three biggest risk factors, in order, for hepatits B?
|
1) heterosexual sex; 2) injecting drug use; 3) homosexual activity
|
|
what in the serology determines whether a person will recover from hepatisis B or progress to chronic hepatitis B infection?
|
whether or not they develop the anti-HBs antibody
|
|
of HBsAg, anti-HBs, and anti-HBc, which are positive during the early (presymptomatic) acute type B hepatitis?
|
only HBsAg
|
|
of HBsAg, anti-HBs, and anti-HBc, which are positive during the "window" of HBV infection?
|
anti-HBc (IgM)
|
|
of HBsAg, anti-HBs, and anti-HBc, which are positive during acute or chronic type B hepatitis?
|
HBsAg, anti-HBc
|
|
of HBsAg, anti-HBs, and anti-HBc, which are positive during recovery from type B hepatitis?
|
anti-HBs, anti-HBc
|
|
of HBsAg, anti-HBs, and anti-HBc, which are positive during immediate recovery phase from type B hepatitis or "low level" carrier state?
|
anti-HBc
|
|
of HBsAg, anti-HBs, and anti-HBc, which are positive after immunization with HBsAg?
|
anti-HBs
|
|
which can be positive long after hepatitis B infection?
|
either anti-HBs or anti-HBc
|
|
in what bodily fluids is HBV in high concentration (3)?
|
blood, serum, wounds
|
|
in what bodily fluids is HBV in moderate concentrations (3)?
|
semen, vaginal fluid, saliva
|
|
in what bodily fluids is HBV in low levels or not detectable (5)?
|
urine, feces, sweat, tears, breast milk
|
|
what is the msot severe consequence of hepatitis B infections due to?
|
the presence of the delta agent - a very small, defective RNA virus that requires HBV to cause disease
|
|
what does it increase the likelihood of (2) and how does it increase the likelihood of each?
|
1) fulminant hepatitis (with coinfection); 2) chronic active hepatitis (with superinfection)
|
|
***review hepatitis B graphs and charts (outcome by age, serological course)***
|
|
|
|
|
|
CHRONIC HEPATITIS
|
|
|
|
|
|
how long does chronic hepatitis last, and what viruses cause it?
|
>6 months, HBV and HCV
|
|
what seems to be happening with the terms used to describe chronic hepatitis?
|
they are being replaced by statements concerning etiology, severity (with regard to necrosis and inflammation), and stage with regard to the degree of fibrosis and progression toward cirrhosis
|
|
what are the current two classes of chronic hepatitis?
|
1) non-progressive (persistent); 2) progressive (active)
|
|
what % of what viruses account for chronic non-progressive (persistent) hepatitis?
|
10-12% of HBV, and a proportion of HCV as well
|
|
what is non-progressive (persistent) hepatitis like clinically?
|
prolonged, slow recovery without sequelae
|
|
what lab value changes, and what symptoms does this cause?
|
asymptomatic rise in serum transaminase
|
|
what morphologic changes occur in chronic non-progressive (persistent) hepatitis (2)?
|
1) mild inflammation; 2) evidence of hepatocellular degeneration and regeneration
|
|
what appearance often occurs due to the hepatocellular regeneration in non-progressive hepatitis?
|
cobblestone appearance
|
|
in what % of hepatitis B and C cases is chronic progressive (active) hepatitis seen?
|
in over 25% of hepatitis C, 1-3% of hepatitis B
|
|
in what other condition is it the clinicopathologic finding?
|
in autoimmune (lupoid) hepatitis
|
|
what is disease like?
|
multiple episodes of mild, often anicteric disease, with increased transaminase
|
|
how can it progress?
|
may be symptomatic initially, but may lead to cirrhosis, liver failure, and death
|
|
what is the morphologic pattern of chronic progressive (active) hepatitis?
|
bridging necrosis with "piecemeal" necrosis and inflammation
|
|
what is inflamed?
|
the limiting plate
|
|
what may or may not be present?
|
fibrosis, which may lead to progressive fibrosis and cirrhosis
|
|
what things are graded when assessing chronic hepatitis severity (3)?
|
1) grade of portal inflammatory activity; 2) grade of lobular inflammatory activity; 3) stage of fibrosis
|
|
what is the scale of portal inflammatory activity?
|
0 (none) to 4 (severe piecemeal necrosis)
|
|
what is the scale of lobular inflammatory activity?
|
0 (none) to 4 ( bridging necrosis)
|
|
what is the scale of fibrosis?
|
0 (none) to 4 (cirrhosis)
|
|
|
|
|
HEPATITIS C
|
|
|
|
|
|
how many genotypes and subtypes are there?
|
6 genotypes, >90 subtypes
|
|
what virus family does HCV belong to?
|
flaviviridae
|
|
what types of HCV account for 75% of cases in the USA?
|
1a and 1b
|
|
how does pathogenicity vary between HCV types?
|
all types are equally pathogenic
|
|
what do types 2 and 3 respond better to than type 1?
|
alpha interferon
|
|
what is the average incubation period, and incubation period range, for HCV infection?
|
average 6-7 weeks, range 2-26 weeks
|
|
what is the acute illness like, and what is the rate?
|
mild <20%
|
|
what % have chronic hepatitis?
|
70% (most asymptomatic)
|
|
what % go on to cirrhosis?
|
10-20%
|
|
what % die from CLD?
|
1-5%
|
|
what is the serological course like?
|
anti HCV always develops
|
|
what are ALT levels like?
|
increase in the symptomatic phase (2nd-5th months or so) and decrease in the first six months, then rise and fall in a jagged line pattern
|
|
what % of chronic liver disease is HCV related?
|
40-60%
|
|
how many people have chronic HCV infection in the USA?
|
2.7 million
|
|
hwo many people die from chronic HCV disease every year?
|
8,000 - 10,000
|
|
what is the most common source for HCV infection?
|
injecting drug use
|
|
what group has the highest prevalence of HCV?
|
hemopheliacs - although transfusions are no longer very dangerous
|
|
what % of IV drug users are infected after 5 years?
|
60-90%
|
|
what % of acute cases are transmitted sexually?
|
10-20%
|
|
what % of long term partners spread HCV?
|
1.50%
|
|
what type of transmission is most efficient?
|
male to female
|
|
what is the risk of transmission from a needle stick?
|
1.8% per stick (1/10 HBV)
|
|
what is the rate of perinatal transmission from women HCV-RNA positive at delivery?
|
5%
|
|
when is this rate higher?
|
when woman is HIV positive (17%)
|
|
what is the prognosis for infected infants?
|
they do well
|
|
what was it said there is no association with, in perinatal transmission (2)?
|
1) breast feeding; 2) delivery method
|
|
how common is severe hepatitis, in perinatal transmission?
|
rare
|
|
how common is household transmission of HCV?
|
rare, but not absent
|
|
how could it occur?
|
through percutaneous/mucosal exposures to blood (razors, toothbrushes, injections, folk remidies)
|
|
of those who have persistent hepatitis C, how many have stable chronic hepatitis (%)?
|
30%
|
|
of the other 70% which have variable (40%) and severe (30%) progression, how many respond to antiviral treatments?
|
35% respond, treatment fails in 65%
|
|
what are factors promoting progression of HCV (4)?
|
1) increased alcohol intake; 2) male; 3) over 40 years at time of infection; 4) coinfections (HIV, HBV)
|
|
|
|
|
HEPATITIS E VIRUS
|
|
|
|
|
|
what is the incubation period of hepatitis E (average and range)?
|
average 40 days, range 15-60 days
|
|
what is the overall fatality rate?
|
1%-3%
|
|
what group has a higher fatality rate, and what is it?
|
pregnant women - 15-25%
|
|
what other factor increases illness severity?
|
age
|
|
what are chronic sequelae?
|
none
|
|
what are most outbreaks associated with?
|
fecally contaminated drinking water
|
|
how do most US cases arise?
|
history of travel to HEV endemic areas
|
|
what type of transmission is minimal?
|
person to person
|
|
|
|
|
OTHER CAUSES OF HEPATITIS
|
|
|
|
|
|
what are other viral causes of hepatitis (4)?
|
1) HSV; 2) CMV; 3) adenovirus; 4) EBV
|
|
what alleles is autoimmune hepatitis associated with (4)?
|
HLA alleles - B8, Dr3, Dr52, and Dr4
|
|
what is the therapy (2)?
|
prednisone +/- azathioprine (not interferon as opposed to viral hepatitis, may require transplantation)
|
|
what is the clinical presentation like?
|
quite variable
|
|
who does type 1 (classic) autoimmune hepatitis typically occur in?
|
postmenopausal women
|
|
what may it present as (2)?
|
1) infertility; 2) endocrine dysfunction
|
|
what other diseases may it be associated with?
|
other autoimmune diseases such as thyroiditis, diabetes, or hemolytic anemia
|
|
what % recover without therapy?
|
only 20%
|
|
what antibodies are notably present (2)?
|
hypergammaglobulinemia with a wide variety, but most notably: 1) anti-smooth muscle; 2) ANA
|
|
who does type 2 autoimmune hepatitis often occur in?
|
female children (younger than type 1)
|
|
how does it compare to type 1?
|
often more aggressive and resistant to therapy than type 1
|
|
what antibody is it associated with?
|
anti-LKM-1 (liver kidney microsomal) rather than anti-smooth muscle
|
|
what does autoimmune hepatitis look like pathologically?
|
like viral chronic active hepatitis
|
|
what is one difference?
|
autoimmune hepatitis has more plasma cells in the portal infiltrate
|
|
what other diseases may look similar?
|
other autoimmune hepatic diseases such as primary biliary cirrhosis and sclerosing cholangitis
|
|
what are hints of drug induced liver disease (5)?
|
1) disproportionate necrosis; 2) eosinophilia; 3) fatty change; 4) granulomas; 5) disappropriate cholestasis
|
|
what are example drugs that cause liver damage (4)?
|
tylenol, INH, methyldopa, halothane, etc. (the list is long)
|